Superficial thrombophlebitis in ipsilateral breast after COVID-19 vaccination

On December 2020, the US Food and Drug Administration issued the first emergency use authorization for a vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We report development of superficial thrombophlebitis in...

Descripción completa

Detalles Bibliográficos
Autores principales: Aran, Shima, Kayder, Orest O., Chopra, Teena, Abujudeh, Hani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189435/
https://www.ncbi.nlm.nih.gov/pubmed/35711742
http://dx.doi.org/10.1016/j.radcr.2022.05.018
_version_ 1784725588032880640
author Aran, Shima
Kayder, Orest O.
Chopra, Teena
Abujudeh, Hani
author_facet Aran, Shima
Kayder, Orest O.
Chopra, Teena
Abujudeh, Hani
author_sort Aran, Shima
collection PubMed
description On December 2020, the US Food and Drug Administration issued the first emergency use authorization for a vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We report development of superficial thrombophlebitis in the ipsilateral breast of a 43-year-old female 7 days after receiving the first dose of the Pfizer-BioNTech COVID-19 vaccine. Given that this is the first case of superficial thrombophlebitis in the breast shortly after mRNA vaccination for COVID-19 reported to our knowledge, we suggest that this may be a rare vaccine-related event.
format Online
Article
Text
id pubmed-9189435
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-91894352022-06-13 Superficial thrombophlebitis in ipsilateral breast after COVID-19 vaccination Aran, Shima Kayder, Orest O. Chopra, Teena Abujudeh, Hani Radiol Case Rep Case Report On December 2020, the US Food and Drug Administration issued the first emergency use authorization for a vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We report development of superficial thrombophlebitis in the ipsilateral breast of a 43-year-old female 7 days after receiving the first dose of the Pfizer-BioNTech COVID-19 vaccine. Given that this is the first case of superficial thrombophlebitis in the breast shortly after mRNA vaccination for COVID-19 reported to our knowledge, we suggest that this may be a rare vaccine-related event. Elsevier 2022-06-13 /pmc/articles/PMC9189435/ /pubmed/35711742 http://dx.doi.org/10.1016/j.radcr.2022.05.018 Text en © 2022 The Authors. Published by Elsevier Inc. on behalf of University of Washington. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Aran, Shima
Kayder, Orest O.
Chopra, Teena
Abujudeh, Hani
Superficial thrombophlebitis in ipsilateral breast after COVID-19 vaccination
title Superficial thrombophlebitis in ipsilateral breast after COVID-19 vaccination
title_full Superficial thrombophlebitis in ipsilateral breast after COVID-19 vaccination
title_fullStr Superficial thrombophlebitis in ipsilateral breast after COVID-19 vaccination
title_full_unstemmed Superficial thrombophlebitis in ipsilateral breast after COVID-19 vaccination
title_short Superficial thrombophlebitis in ipsilateral breast after COVID-19 vaccination
title_sort superficial thrombophlebitis in ipsilateral breast after covid-19 vaccination
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189435/
https://www.ncbi.nlm.nih.gov/pubmed/35711742
http://dx.doi.org/10.1016/j.radcr.2022.05.018
work_keys_str_mv AT aranshima superficialthrombophlebitisinipsilateralbreastaftercovid19vaccination
AT kayderoresto superficialthrombophlebitisinipsilateralbreastaftercovid19vaccination
AT choprateena superficialthrombophlebitisinipsilateralbreastaftercovid19vaccination
AT abujudehhani superficialthrombophlebitisinipsilateralbreastaftercovid19vaccination

Ejemplares similares